2002
DOI: 10.2165/00003495-200262020-00009
|View full text |Cite
|
Sign up to set email alerts
|

Quinapril

Abstract: Quinapril is now firmly established as an effective and well tolerated ACE inhibitor for the treatment of patients with hypertension and congestive heart failure. Quinapril 40 mg/day also significantly reduced the incidence of ischaemic events in patients undergoing CABG in one study; however, a lower dosage of quinapril (20 mg/day) had no effect on ischaemic events in patients undergoing coronary angioplasty in another trial. Additional trials in patients with coronary artery disease receiving optimal dosages… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 193 publications
0
2
0
Order By: Relevance
“…From the large array of available ACE inhibitors we deliberately used quinapril, because this formulation was claimed to achieve the highest tissue concentrations in the kidney, and thus presumably optimal inhibition of local tissue RAAS [21]. …”
Section: Discussionmentioning
confidence: 99%
“…From the large array of available ACE inhibitors we deliberately used quinapril, because this formulation was claimed to achieve the highest tissue concentrations in the kidney, and thus presumably optimal inhibition of local tissue RAAS [21]. …”
Section: Discussionmentioning
confidence: 99%
“…Quinapril, a member of the ACE inhibitor family, is widely used for treating hypertension and CHF [4]. Recent studies * Corresponding author.…”
Section: Introductionmentioning
confidence: 99%